{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:20:19Z","timestamp":1787847619817,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The global coronavirus disease 2019 (COVID-19) outbreak has resulted in a significant number of infections, particularly among individuals with type 2 diabetes, who are at an increased risk. Our goal was to examine how COVID-19 has affected hematological parameters and coagulation markers in elderly patients diagnosed with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study conducted at tertiary-care hospitals in Tabuk focused on patients with type 2 diabetes mellitus who were also infected with COVID-19. The research included patients aged 45 and older, all of whom had at least 6 months of a type 2 diabetes diagnosis. Patients were excluded from the study if they had active malignancies, recent changes in their antidiabetic medications, severe infections or surgeries, or decompensated liver disease or heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study included 65 patients. During the COVID-19 pandemic, patients with type 2 diabetes exhibited a notable decrease in red blood cell count, hemoglobin concentration, hematocrit value, and platelet count, accompanied by a significant increase in red cell distribution width, mean platelet volume, prothrombin time, and activated partial thromboplastin time. Following the complete recovery of patients from COVID-19, all hematological parameters reverted to their pre-COVID-19 infection levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Patients diagnosed with type 2 diabetes and COVID-19 may experience hematological dysregulation, characterized by decreased red blood cell counts, hemoglobin levels, and hematocrit values, predisposing them to anemia. Additionally, they are at an increased risk of bleeding due to reduced platelet count, prolonged prothrombin time, and activated partial thromboplastin time. The results are not affected by gender.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_5_25","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T06:00:49Z","timestamp":1752904849000},"page":"2974-2979","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effect of COVID-19 on hematological parameters and subsequent risk of anemia and bleeding in middle-aged and elderly patients with type 2 diabetes"],"prefix":"10.4103","volume":"14","author":[{"given":"Abdulazez N.","family":"Alqhtani","sequence":"first","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shemah S.","family":"AlHwiti","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind M.","family":"AlAtwi","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeshah H.","family":"AlBuhayri","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrazaq S.","family":"AlMasoudi","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad F.","family":"AlShamari","sequence":"additional","affiliation":[{"name":"PharmD Program, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind M.","family":"Alaidi","sequence":"additional","affiliation":[{"name":"Director of Training and Academic Affairs, King Fahd Specialist Hospital, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M. S.","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Director of Outpatient Department, King Fahd Specialist Hospital, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf A.","family":"Alanazi","sequence":"additional","affiliation":[{"name":"Patient Experience Director, King Fahd Specialist Hospital, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aljabri","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad","family":"Alshibani","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M. H.","family":"Al-Gayyar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt"},{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"171","DOI":"10.24095\/hpcdp.43.4.02","article-title":"Social isolation, loneliness and positive mental health among older adults in Canada during the COVID-19 pandemic","volume":"43","author":"Ooi","year":"2023","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/met.2020.0037","article-title":"Diabetes and the COVID-19 pandemic: How insights from recent experience might guide future management","volume":"18","author":"Stoian","year":"2020","journal-title":"Metab Syndr Relat Disord"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/imm.13706","article-title":"The alterations of innate immunity and enhanced severity of infections in diabetes mellitus","volume":"171","author":"Zhou","year":"2024","journal-title":"Immunology"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)-United States, February 12-March 16, 2020","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12933-020-01184-4","article-title":"Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: A single-centre retrospective study","volume":"19","author":"Alguwaihes","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10654-020-00678-5","article-title":"Anemia and iron metabolism in COVID-19: A systematic review and meta-analysis","volume":"35","author":"Taneri","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1753495X231206931","article-title":"Report of the ISTH registry on pregnancy and COVID-19-associated coagulopathy (COV-PREG-COAG)","volume":"17","author":"Kazi","year":"2024","journal-title":"Obstet Med"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3390\/biomedicines12061234","article-title":"Hemoglobin and its relationship with fatigue in long-COVID patients Three to six months after SARS-CoV-2 infection","volume":"12","author":"Bazdar","year":"2024","journal-title":"Biomedicines"},{"key":"R9-20250804","first-page":"e35390","article-title":"Effect of COVID-19 on glycemic control, insulin resistance, and pH in elderly patients with type 2 diabetes","volume":"15","author":"Alshammari","year":"2023","journal-title":"Cureus"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"23247096231207687","DOI":"10.1177\/23247096231207687","article-title":"Hematologic abnormalities after COVID-19 infection: A case of coombs-negative hemolytic anemia and thrombocytopenia","volume":"11","author":"Siegenthaler","year":"2023","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R11-20250804","first-page":"e58589","article-title":"Coombs-negative hemolytic anemia in an elderly COVID-19 patient","volume":"16","author":"Sanikommu","year":"2024","journal-title":"Cureus"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/pathogens12020184","article-title":"COVID-19: Diabetes perspective-pathophysiology and management","volume":"12","author":"Dallavalasa","year":"2023","journal-title":"Pathogens"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"3000605221078699","DOI":"10.1177\/03000605221078699","article-title":"Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran;a case-control study","volume":"50","author":"Changaripour","year":"2022","journal-title":"J Int Med Res"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1080\/15384101.2020.1859197","article-title":"Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha\/-beta inhibitor chelerythrine -possible therapeutic implication","volume":"19","author":"Ghashghaeinia","year":"2020","journal-title":"Cell Cycle"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"578708","DOI":"10.3389\/fphys.2021.578708","article-title":"The affinity of hemoglobin for oxygen is not altered during COVID-19","volume":"12","author":"Gille","year":"2021","journal-title":"Front Physiol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.resinv.2020.10.009","article-title":"Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia","volume":"59","author":"Anai","year":"2021","journal-title":"Respir Investig"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/CH-131792","article-title":"Erythrocyte aggregation and metabolic syndrome","volume":"57","author":"Gyawali","year":"2014","journal-title":"Clin Hemorheol Microcirc"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.jtha.2024.08.030","article-title":"\u201cFour years into the pandemic, managing COVID-19 patients with acute coagulopathy: What have we learned?\u201d Comment from Wada et al","volume":"22","author":"Wada","year":"2024","journal-title":"J Thromb Haemost"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JBM.S457545","article-title":"Can COVID-19 increase platelet in adult immune thrombocytopenia during the TPO-RA administration? A real-world observational study","volume":"15","author":"Wang","year":"2024","journal-title":"J Blood Med"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"1361082","DOI":"10.3389\/fchem.2024.1361082","article-title":"Modulation in serum and hematological parameters as a prognostic indicator of COVID-19 infection in hypertension, diabetes mellitus, and different cardiovascular diseases","volume":"12","author":"Jan","year":"2024","journal-title":"Front Chem"},{"key":"R21-20250804","first-page":"8862457","article-title":"Exploring hematological parameters and their prognostic value in adult COVID-19 patients: Insights from Mogadishu, Somalia","author":"Ali Mude","year":"2023","journal-title":"Adv Hematol 2023"},{"key":"R22-20250804","first-page":"3","article-title":"The effects of thrombocytopenia, type 2 diabetes mellitus, and endothelial dysfunction on clinical outcomes in patients with COVID-19","author":"Faisal","year":"2022","journal-title":"Qatar Med J 2023"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1002\/edm2.391","article-title":"Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana-A single-center study","volume":"6","author":"Hardy","year":"2023","journal-title":"Endocrinol Diabetes Metab"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00134-022-06705-1","article-title":"Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: The global UNITE-COVID study","volume":"48","author":"Greco","year":"2022","journal-title":"Intensive Care Med"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/09537104.2020.1754383","article-title":"Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study","volume":"31","author":"Liu","year":"2020","journal-title":"Platelets"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"3804576","DOI":"10.1155\/cjid\/3804576","article-title":"Thromboembolic events in the era of COVID-19: A detailed narrative review","author":"Abou Mansour","year":"2025","journal-title":"Can J Infect Dis Med Microbiol 2025"},{"key":"R27-20250804","first-page":"e78797","article-title":"A review of the hematological picture of severe COVID-19 infection","volume":"17","author":"Amoroso","year":"2025","journal-title":"Cureus"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"9287329251327481","DOI":"10.1177\/09287329251327481","article-title":"Insights into biochemical, hematological, and coagulation parameters and their association with COVID-19 severity within four patients cohort from Bosnia and Herzegovina","volume":"30","author":"Meseld\u017ei\u0107","year":"2025","journal-title":"Technol Health Care"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_5_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:24:30Z","timestamp":1787844270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_5_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_5_25","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-01-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}